Aug. 27--Sandoz’s pill manufacturing plant in Wilson failed to follow safeguards to ensure several of its medicines were made the same way every time. The Food and Drug Administration noted the violations during a two-week inspection in March. Since then, the plant has also failed to properly follow up on the violations, the FDA wrote in a warning letter mailed Aug. 12.
